documents: FDA-2005-D-0460-0007
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-D-0460-0007 | FDA | FDA-2005-D-0460 | Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act Guidance for Industry | Other | Guidance | 2023-05-18T04:00:00Z | 2023 | 5 | 2023-05-18T04:00:00Z | 2023-07-18T03:59:59Z | 2026-01-10T12:32:26Z | 1 | 0 | 0900006485a1cc08 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref